Projected to grow from US$5.92 billion in 2024 to US$12.83 billion by 2033 at 8.1% CAGR, the Parkinson's disease therapeutics market thrives on drug classes and hospitals. Dive into segmentation by disease type, key approvals, and challenges in early-onset cases (4% before age 50). https://finance.yahoo.com/news/parkinsons-disease-therapeutics-market-size-143000110.html